These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Binding of estramustine, a nitrogen mustard derivative of estradiol-17 beta, in cytosol from rat ventral prostate. Forsgren B; Högberg B; Gustafsson JA; Pousette A Acta Pharm Suec; 1978; 15(1):23-32. PubMed ID: 645366 [No Abstract] [Full Text] [Related]
4. Subcellular localization of estramustine in rat ventral prostate following intravenous injection. Peterson C; Forsgren B; Högberg B Acta Physiol Scand Suppl; 1983; 515():55-63. PubMed ID: 6578672 [No Abstract] [Full Text] [Related]
5. The hydrolysis of estramustine phosphate; in vitro studies. Gunnarsson O; Andersson SB; Johansson SA Eur J Drug Metab Pharmacokinet; 1983; 8(4):395-402. PubMed ID: 6673977 [TBL] [Abstract][Full Text] [Related]
6. Binding characteristics of a major protein in rat ventral prostate cytosol that interacts with estramustine, a nitrogen mustard derivative of 17 beta-estradiol. Forsgren B; Gustafsson JA; Pousette A; Högberg B Cancer Res; 1979 Dec; 39(12):5155-64. PubMed ID: 40694 [TBL] [Abstract][Full Text] [Related]
7. Specific binding of estramustine to prostatic proteins. Forsgren B; Björk P Urology; 1984 Jun; 23(6 Suppl):34-8. PubMed ID: 6375077 [No Abstract] [Full Text] [Related]
8. Relative affinities of estramustine phosphate metabolites to the cytosol oestrogen receptor of rat testis. Daehlin L; Södergård R; Damber JE Scand J Clin Lab Invest; 1986 Apr; 46(2):159-62. PubMed ID: 3715367 [TBL] [Abstract][Full Text] [Related]
10. Metabolic parameters of Estracyt pertinent to its effects in prostatic cancer. Sandberg AA Urology; 1984 Jun; 23(6 Suppl):11-21. PubMed ID: 6375075 [No Abstract] [Full Text] [Related]
11. Metabolism of estramustine phosphate (Estracyt) in patients with prostatic carcinoma. Andersson SB; Gunnarsson PO; Nilsson T; Forshell GP Eur J Drug Metab Pharmacokinet; 1981; 6(2):149-54. PubMed ID: 7274309 [TBL] [Abstract][Full Text] [Related]
12. Estramustine phosphate: metabolic aspects related to its action in prostatic cancer. Kadohama N; Kirdani RY; Murphy GP; Sandberg AA J Urol; 1978 Feb; 119(2):234-9. PubMed ID: 633484 [TBL] [Abstract][Full Text] [Related]
13. [Estracyt (estradiol-nitrogen mustard complex)--estramustine binding protein and its specificity]. Yamanaka H; Imai K; Suzuki T; Yuasa H; Takahashi E Gan To Kagaku Ryoho; 1984 Oct; 11(10):2106-14. PubMed ID: 6486830 [TBL] [Abstract][Full Text] [Related]
14. Studies on the estramustine-binding protein in rat ventral prostate and in human prostate. Gustafsson JA; Björk P; Carlström K; Forsgren B; Hökfelt T; Pousette A; Högberg B Scand J Urol Nephrol Suppl; 1980; 55():133-4. PubMed ID: 6163205 [No Abstract] [Full Text] [Related]
15. Effects of testosterone on estracyt localization in rat prostate. Catane R; Mittelman A; Murphy GP; Sandberg AA Oncology; 1980; 37(5):357-9. PubMed ID: 7443167 [TBL] [Abstract][Full Text] [Related]
16. Purification and distribution of a major protein in rat prostate that binds estramustine, a nitrogen mustard derivative of estradiol-17 beta. Forsgren B; Björk P; Carlström K; Gustafsson JA; Pousette A; Högberg B Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3149-53. PubMed ID: 290993 [TBL] [Abstract][Full Text] [Related]
17. Estramustine-binding protein in rat and human prostate. Forsgren B Scand J Urol Nephrol Suppl; 1988; 107():56-8. PubMed ID: 3287598 [TBL] [Abstract][Full Text] [Related]
18. The absorption metabolism, and excretion of Estracyt (NSC 89199) in patients with prostatic cancer. Forshell GP; Müntzing J; Ek A; Lindstedt E; Dencker H Invest Urol; 1976 Sep; 14(2):128-31. PubMed ID: 972005 [TBL] [Abstract][Full Text] [Related]
19. Autoradiographic studies of 3H-estramustine in the rat ventral prostate. Appelgren LE; Forsgren B; Gustafsson JA; Pousette A; Högberg B Acta Pharmacol Toxicol (Copenh); 1978 Nov; 43(5):368-74. PubMed ID: 726901 [TBL] [Abstract][Full Text] [Related]
20. Estramustine. Metabolic pattern and possible mechanisms for its action in prostate cancer. Kadohama N; Kirdani RY; Madajewicz S; Murphy GP; Sandberg AA N Y State J Med; 1979 Jun; 79(7):1005-9. PubMed ID: 287893 [No Abstract] [Full Text] [Related] [Next] [New Search]